Growth Metrics

Enanta Pharmaceuticals (ENTA) EBIT Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 51.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 51.68%
Dec 31, 2025 52.20%
Sep 30, 2025 38.41%
Jun 30, 2025 21.88%
Mar 31, 2025 25.14%
Dec 31, 2024 32.51%
Sep 30, 2024 3.79%
Jun 30, 2024 34.12%
Mar 31, 2024 16.95%
Dec 31, 2023 -16.24%
Sep 30, 2023 -14.72%
Jun 30, 2023 -12.82%
Mar 31, 2023 -16.56%
Dec 31, 2022 1.30%
Sep 30, 2022 19.80%
Jun 30, 2022 3.86%
Mar 31, 2022 -13.96%
Dec 31, 2021 -147.25%
Sep 30, 2021 -70.48%
Jun 30, 2021 -48.11%
Mar 31, 2021 -150.11%
Dec 31, 2020 -195.56%
Sep 30, 2020 -407.62%
Jun 30, 2020 -708.58%
Mar 31, 2020 -810.66%
Dec 31, 2019 -53.79%
Sep 30, 2019 -81.33%
Jun 30, 2019 -83.41%
Mar 31, 2019 -107.73%
Dec 31, 2018 93.75%
Sep 30, 2018 -36.55%
Jun 30, 2018 272.44%
Mar 31, 2018 277.35%
Dec 31, 2017 304.04%
Sep 30, 2017 1,852.02%
Jun 30, 2017 -1,105.60%
Mar 31, 2017 -1,582.48%
Dec 31, 2016 -119.80%
Sep 30, 2016 -184.35%
Jun 30, 2016 -163.95%
Mar 31, 2016 -101.16%
Dec 31, 2015 -49.30%
Sep 30, 2015 168.98%
Jun 30, 2015 -95.12%
Mar 31, 2015 1,047.16%
Dec 31, 2014 1,386.60%
Sep 30, 2014 -13.30%
Jun 30, 2014 935.21%
Mar 31, 2014 -28.14%
Dec 31, 2013 -124.91%
Sep 30, 2013 -14.77%
Jun 30, 2013 -18.42%
Mar 31, 2013 -112.47%